Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

  • Karachaliou, Marianna|||0000-0002-3014-0747
  • Ranzani, Otavio|||0000-0002-4677-6862
  • Espinosa, Ana|||0000-0001-7399-3267
  • Iraola-Guzmán, Susana|||0000-0003-3359-1241
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Vidal, M.
  • Jiménez, A.
  • Bañuls, Marc
  • Nogués, E.A.
  • Aguilar, R.
  • Garcia-Aymerich, Judith|||0000-0002-7097-4586
  • de Cid, Rafael|||0000-0003-3579-6777
  • Dobaño, C.
  • Moncunill, G.
  • Kogevinas, Manolis|||0000-0002-9605-0461
Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab

  • Jabbour, E.J.|||0000-0003-4465-6119
  • Kantarjian, Hagop M.|||0000-0002-1908-3307
  • Goekbuget, N.
  • Shah, B.D.
  • Chiaretti, S.
  • Park, J.H.|||0000-0002-2903-5130
  • Rijneveld, A.W.
  • Gore, L.
  • Fleming, S.
  • Logan, A.C.
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Menne, T.F.
  • Mezzi, K.
  • Zaman, F.
  • Velasco, K.
  • Boissel, Nicolas|||0000-0003-2091-7927
This narrative review seeks to summarize chemotherapeutic regimens commonly used for patients with newly diagnosed Philadelphia (Ph) chromosome-negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in the frontline setting and to describe the latest clinical research using the bispecific T-cell-engaging immunotherapy blinatumomab in the first-line treatment setting. Current standard-of-care chemotherapeutic backbones for newly diagnosed Ph-negative BCP-ALL are based on the same overarching treatment principle: to reduce disease burden to undetectable levels and maintain lasting remission. The adult treatment landscape has progressively evolved following the adoption of pediatric-inspired regimens. However, these intense regimens are not tolerated by all, and high-risk patients still have inferior outcomes. Therefore, designing more effective and less toxic strategies remains key to further improving efficacy and safety outcomes. Overall, the treatment landscape is evolving in the frontline, and integration of blinatumomab into different standard frontline regimens may improve overall outcomes with a favorable safety profile.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

  • Maxwell, Christopher|||0000-0002-0713-7136
  • Benítez, Javier J.
  • Gómez-Baldó, Laia
  • Osorio, Ana|||0000-0001-8124-3984
  • Bonifaci, Núria|||0000-0002-8193-6825
  • Fernández-Ramires, Ricardo|||0000-0002-6974-2593
  • Costes, Sylvain|||0000-0002-8542-2389
  • Guinó, Elisabet|||0000-0003-0093-2652
  • Chen, Helen
  • Evans, Gareth|||0000-0002-8482-5784
  • Mohan, Pooja
  • Català, Isabel
  • Petit Montserrat, Anna|||0000-0002-9284-095X
  • Aguilar, Helena
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Aytes, Alvaro|||0000-0003-0725-5340
  • Serra-Musach, Jordi
  • Rennert, Gad|||0000-0002-8512-068X
  • Lejbkowicz, Flavio|||0000-0001-5718-0418
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Manoukian, Siranoush
  • Peissel, Bernard|||0000-0001-9233-3571
  • Ripamonti, Carla Barbara|||0000-0002-2892-8164
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Viel, Alessandra|||0000-0003-2804-0840
  • Allavena, Anna
  • Bernard, Loris
  • Radice, Paolo|||0000-0001-6298-4111
  • Friedman, Eitan|||0000-0002-6745-1733
  • Kaufman, Bella
  • Laitman, Yael
  • Dubrovsky, Maya
  • Milgrom, Roni
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Cybulski, Cezary|||0000-0002-2819-3057
  • Gorski, Bohdan
  • Jaworska, Katarzyna
  • Durda, Katarzyna
  • Sukiennicki, Grzegorz
  • Lubinski, Jan|||0000-0003-2931-3003
  • Shugart, Yin Yao
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Letrero, Richard
  • Weber, Barbara L.
  • Hogervorst, Frans B. L.
  • Rookus, Matti A.
  • Collee, J. Magriet
  • Devilee, Peter|||0000-0002-8023-2009
  • Ligtenberg, Marjolijn J.
  • van der Luijt, Rob|||0000-0002-0018-1089
  • Aalfs, Cora M.
  • Waisfisz, Quinten|||0000-0002-7384-9182
  • Wijnen, Juul
  • van Roozendaal, Cornelis E. P.
  • HEBON, None
  • EMBRACE, None
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Peock, Susan
  • Cook, Margaret
  • Oliver, Clare
  • Frost, Debra
  • Harrington, Patricia
  • Lalloo, Fiona
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Izatt, Louise|||0000-0003-1258-4843
  • Chu, Carol
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Brewer, Carole
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Heikkinen, Tuomas|||0000-0003-1154-6204
  • Couch, Fergus J.
  • Wang, Xianshu
  • Lindor, Noralane M.
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Caligo, Maria|||0000-0003-0589-1829
  • Lombardi, Grazia
  • Loman, Niklas
  • Karlsson, Per
  • Ehrencrona, Hans|||0000-0002-5589-3622
  • von Wachenfeldt, Anna
  • SWE-BRCA, None
  • Barkardottir, Rosa
  • Hamann, Ute|||0000-0001-6705-7624
  • Rashid, Muhammad U.|||0000-0002-7684-3122
  • Lasa, Adriana|||0000-0001-9957-9646
  • Caldes, Trinidad
  • Andrés Conejero, Raquel
  • Schmitt, Michael
  • Assmann, Volker
  • Stevens, Kristen
  • Offit, Kenneth
  • Curado, João
  • Tilgner, Hagen U.|||0000-0002-7058-3606
  • Guigó, Roderic|||0000-0002-5738-4477
  • Aiza, Gemma|||0000-0001-8654-3724
  • Brunet, Joan|||0000-0003-1945-3512
  • Castellsagué, Joan|||0000-0002-2579-3137
  • Martrat, Griselda
  • Urruticoechea, Ander|||0000-0003-0359-3641
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Tihomirova, L.
  • Goldgar, D. E.
  • Buys, S.
  • John, Esther M.
  • Miron, A.
  • Southey, M.
  • Daly, M.B.
  • BCFR, None
  • Schmutzler, R.K.
  • Wappenschmidt, B.
  • Meindl, A.
  • Arnold, N.
  • Deissler, H.
  • Varon-Mateeva, Raymonda
  • Sutter, C.
  • Niederacher, D.
  • Imyamitov, E.
  • Sinilnikova, O.M.
  • Stoppa-Lyonne, D.
  • Mazoyer, S.
  • Verny-Pierre, C.
  • Castera, L.
  • de Pauw, A.
  • Bignon, Y.J.
  • Uhrhammer, N.
  • Peyrat, J.P.
  • Vennin, P.
  • Ferrer, S.
  • Collonge-Rame, M.A.
  • Mortemousque, I.
  • GEMO Study Collaborators, None
  • Spurdle, A.B.
  • Beesley, J.
  • Chen, X.
  • Healey, S.
  • Barcellos-Hoff, M.H.
  • Gruber, S.B.
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Capella, Gabriel|||0000-0002-4669-7320
  • McGuffog, L.
  • Antoniou, A.C.
  • Chenevix-Trench, G.
  • Fleisch, M.C.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio (<inf.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands

  • Díaz-Tejedor, A.
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ciudad, Laura|||0000-0002-5219-6792
  • Lorenzo-Mohamed, M.
  • González-Rodríguez, M.
  • Castellanos, B.
  • Sotolongo-Ravelo, J.
  • San-Segundo, L.
  • Corchete, L.A.
  • González-Méndez, L.
  • Martín Sánchez, Montserrat
  • Mateos, M. V.|||0000-0003-2390-1218
  • Ocio, Enrique M.|||0000-0002-5765-0085
  • Garayoa, M.
  • Paíno, T.
Multiple myeloma is a malignancy characterized by the accumulation of malignant plasma cells in bone marrow and the production of monoclonal immunoglobulin. A hallmark of cancer is the evasion of immune surveillance. Histone deacetylase inhibitors have been shown to promote the expression of silenced molecules and hold potential to increase the anti-MM efficacy of immunotherapy. The aim of the present work was to assess the potential effect of tinostamustine (EDO-S101), a first-in-class alkylating deacetylase inhibitor, in combination with daratumumab, an anti-CD38 monoclonal antibody (mAb), through different preclinical studies. Tinostamustine increases CD38 expression in myeloma cell lines, an effect that occurs in parallel with an increment in CD38 histone H3 acetylation levels. Also, the expression of MICA and MICB, ligands for the NK cell activating receptor NKG2D, augments after tinostamustine treatment in myeloma cell lines and primary myeloma cells. Pretreatment of myeloma cell lines with tinostamustine increased the sensitivity of these cells to daratumumab through its different cytotoxic mechanisms, and the combination of these two drugs showed a higher anti-myeloma effect than individual treatments in ex vivo cultures of myeloma patients' samples. In vivo data confirmed that tinostamustine pretreatment followed by daratumumab administration significantly delayed tumor growth and improved the survival of mice compared to individual treatments. In summary, our results suggest that tinostamustine could be a potential candidate to improve the efficacy of anti-CD38 mAbs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short-term exposure to desert dust and sandstorms and all-cause and cause-specific mortality and morbidity, A systematic review and meta-analysis

  • Tobías, A.
  • Querol Carceller, Xavier|||0000-0002-6549-9899
  • Roqué i Figuls, Marta|||0000-0003-0043-1364
  • Suu Lwin, K.
  • Yuan, L.
  • Ith, Sophearen
  • Zin Wai, H.
  • Lester Chua, P.
  • Solá, I.
  • Renzi, M.
  • Stafoggia, M.
  • Hashizume, M.
Background: Desert dust and sandstorms raise concerns about their adverse effects on human health. Over the last decade, special attention has been given to mineral dust particles from desert sand. However, evidence from previous literature reviews has yielded inconclusive results regarding their health effects. We aim to systematically synthesize evidence on the short-term health effects of desert dust exposure from major dust source areas. Methods: The bibliographic search was conducted using the MEDLINE (PubMed), Scopus, and Web of Science databases to investigate the health effects of short-term exposure to desert dust in human populations, using time series or case-crossover study designs. Study selection and reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We evaluated the risk of bias (RoB) for individual studies and the certainty of evidence (CoE) for environmental exposures, as developed by a group of experts convened by the World Health Organization (WHO). Publication bias was examined using funnel plots and Begg's asymmetry test. Results: A total of 71 studies were included in the review, covering data from 1993 to 2024. Most studies focused on Asian and African desert dust, with fewer studies from Arabian, American, and Australian regions. We found a significant increase in the risk for all-cause mortality (Relative Risk, RR = 1.0121, 95 %CI = [1.0045, 1.0199]). In addition, the mortality risk associated with particulate matter less than 10 μm (PM10) was slightly higher on dust days compared to non-dust days, while for particulate matter less than 2.5 μm (PM2.5), the risk was higher on non-dust days. We also observed a significant increase in the risk for cardiovascular mortality (RR = 1.0252, 95 % CI = [1.0100, 1.0407]) during dust days compared to non-dust days, but not for respiratory mortality (RR = 1.0001, 95 % CI = [0.9773, 1.0277]). The risk also increased for cardiovascular (RR = 1.0094, 95 % CI = [1.0014, 1.0174]) and respiratory morbidity (RR = 1.0693, 95 % CI = [1.0188, 1.1224]). Conclusion: Exposure to desert dust and sandstorms is linked to increased risks of all-cause and cardiovascular mortality, as well as respiratory morbidity. The overall evidence quality for each exposure-outcome combination was assessed as moderate, although data limitations prevent the establishment of specific air quality thresholds for desert dust particles. This review highlights the need for targeted public health interventions in affected regions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Toluene early morning peaks as potential biogenic stress signals of Mediterranean forests

  • Yáñez Serrano, Ana María|||0000-0001-6408-5961
  • Lampadariou, Mirto
  • Filella, Iolanda|||0000-0001-6262-5733
  • Llusia, Joan|||0000-0003-0164-2737
  • Seco, Roger|||0000-0002-2078-9956
  • Fernández-Martínez, Marcos|||0000-0002-5661-3610
  • Portillo-Estrada, Miguel|||0000-0002-0348-7446
  • Mihalopoulos, Nikolaos|||0000-0002-1282-0896
  • Massagué, Jordi|||0000-0003-0099-2014
  • Perez, Noemi|||0000-0003-2420-6727
  • Savadkoohi, Marjan|||0000-0002-3707-2601
  • Pandolfi, Marco|||0000-0002-7493-7213
  • Peñuelas, Josep|||0000-0002-7215-0150
  • Querol Carceller, Xavier|||0000-0002-6549-9899
  • Alastuey, Andrés|||0000-0002-5453-5495
Mediterranean forests emit biogenic volatile organic compounds (BVOCs) that significantly influence atmospheric chemistry and ecosystem functioning. Due to high solar radiation and the important anthropogenic emission of atmospheric pollutants in the Western Mediterranean Basin, photochemical activity is enhanced, favouring the formation of ozone and secondary organic aerosols. We measured ambient mixing ratios of volatile organic compounds (VOCs) using Proton Transfer Reaction Mass Spectrometry (PTR-MS) at Montseny Natural Park, a Mediterranean forest 60 km from Barcelona, during summers 2021–2023. Surprisingly, during heat wave conditions, a toluene early morning peak of 0.23 (interquartile range 0.18) ppbv was observed. These early morning peaks were associated with prolonged high temperatures (approximately 5 °C higher as compared to non-peak days) and persistently higher vapour pressure deficit (approximately 877 Pa higher as compared to non-peak days), suggesting a potential link to vegetation drought stress. Cross-validation of measurements with Gas Chromatography-Mass Spectrometry (GC-MS) enhanced data reliability. Analysis of the meteorology and the variability of other atmospheric pollutants at the site, allowed to attribute these peaks to a local biogenic origin. These findings suggest that early morning toluene peaks could serve as an indicator of Mediterranean forest vulnerability to climate-induced stressors, with potentially more frequent and intense peaks occurring in the future.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Drivers of biogenic volatile organic compound emissions in hygrophytic bryophytes

  • Yáñez Serrano, Ana María|||0000-0001-6408-5961
  • Corbera, Jordi|||0000-0003-3583-3929
  • Portillo-Estrada, Miguel|||0000-0002-0348-7446
  • Janssens, Ivan|||0000-0002-5705-1787
  • Llusia, Joan|||0000-0003-0164-2737
  • Filella, Iolanda|||0000-0001-6262-5733
  • Peñuelas, Josep|||0000-0002-7215-0150
  • Preece, Catherine|||0000-0001-6584-3541
  • Sabater i Comas, Francesc|||0000-0001-6767-231X
  • Fernández-Martínez, M.
Bryophytes can both emit and take up biogenic volatile organic compounds (BVOCs) to and from the environment. Despite the scarce study of these exchanges, BVOCs have been shown to be important for a wide range of ecological roles. Bryophytes are the most ancient clade of land plants and preserve very similar traits to those first land colonisers. Therefore, the study of these plants can help understand the early processes of BVOC emissions as an adaptation to terrestrial life. Here, we determine the emission rates of BVOCs from different bryophyte species to understand what drives such emissions. We studied 26 bryophyte species from temperate regions that can be found in mountain springs located in NE Spain. Bryophyte BVOC emission presented no significant phylogenetic signal for any of the compounds analysed. Hence, we used mixed linear models to investigate the species-specific differences and eco-physiological and environmental drivers of bryophyte BVOC emission. In general, species-specific variability was the main factor explaining bryophyte BVOC emissions; but additionally, photosynthetic rates and light intensity increased BVOC emissions. Despite emission measurements reported here were conducted at 30°, and may not directly correspond to emission rates in natural conditions, most of the screened species have never been measured before for BVOC emissions and therefore this information can help understand the drivers of the emissions of BVOCs in bryophytes.